Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Vasomotor Rhinitis Clinical Trial

Official title:
Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial

Status Completed

Clinical Trial Summary

The purpose of this study was to see if high dose esomeprazole (40mg bid) was effective in treating non-allergic rhinitis

n/a

NCT number	NCT00745849
Study type	Interventional
Source	University of Texas Southwestern Medical Center
Contact
Status	Completed
Phase	N/A
Start date	June 2005
Completion date	March 2008

See also
Status	Clinical Trial	Phase
Completed	`NCT00979615` - Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis	Phase 4
Completed	`NCT01509209` - Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis	Phase 3
Recruiting	`NCT05348148` - Comparison of the Effects for Lightening the Shiners Among Different Treatments for Rhinitis	N/A
Completed	`NCT00118703` - Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis	Phase 3
Completed	`NCT00682162` - Impact of Acupuncture on Vasomotor Rhinitis	Phase 3
Completed	`NCT00415493` - Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation	N/A
Completed	`NCT00976209` - Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED)	Phase 3